Was COVID-19 Field-Tested in Indian Labs in 2018? A Deep Dive into the Silent Storm

By Nishani | Truth Comes First | Nishani.in


In 2018, long before the world knew what “COVID-19” meant, something strange was already stirring in India’s medical corridors. Specifically, in the sterile labs and wards of AIIMS (All India Institute of Medical Sciences), reports began emerging of flu-like illnesses among lab workers. Symptoms were oddly severe, persistent, and showed signs unfamiliar to traditional strains of influenza. Cases were hushed. No official diagnosis. No media noise. Just an unexplained pattern that came and went — or so we thought.

Now, as we look back in the post-pandemic haze, the big question emerges: Was COVID-19 field-tested in Indian labs as early as 2018? Was India unknowingly a silent test zone for something far more sinister?


⚠️ The Unspoken Incidents of 2018

  • AIIMS researchers and hospital staff, according to insider leaks, experienced a peculiar wave of flu-like infections in mid-to-late 2018.
  • The symptoms were unusually respiratory-focused, accompanied by loss of taste and smell, persistent cough, and a type of pneumonia that wasn’t responding to known treatments.
  • Curiously, a few cases involved lung fibrosis, an after-effect later linked with severe COVID-19 patients — two years before Wuhan blew the whistle.

Why didn’t this become public knowledge? The answer lies in India’s rigid medical hierarchy and silence culture. “Don’t create panic” has always been the go-to excuse. But what if it wasn’t just bureaucratic inertia? What if there was a larger global agenda?


🔬 Field-Testing or Freak Coincidence?

Here’s where the threads get murky:

  • In 2017, the world witnessed an increase in gain-of-function research, much of it debated for ethical and safety reasons. This type of research intentionally makes viruses more infectious in lab settings to study potential outbreaks.
  • India, being a low-cost research hub with less stringent lab audit standards, became a potential site for outsourced medical experimentation — quietly and with plausible deniability.
  • Reports suggest MNCs and foreign research collaborators working alongside Indian labs in 2018. Several projects were “classified” under “bio-defense collaborations.”

Was something being released intentionally or was this an accidental exposure that predated Wuhan? Either way, the implications are chilling.


🤐 Why the Silence?

Here’s the uncomfortable reality:

  • No whistleblower protection in India’s scientific community.
  • State-controlled health institutions avoid damaging national image, even if it costs lives.
  • International research funders often sign non-disclosure agreements (NDAs) with collaborating labs in India.

So even if AIIMS or any other Indian lab realized what they were handling, it’s likely they were either silenced, discredited, or simply ignored.


🌐 Who Benefits from a Silent Test Zone?

  • Pharma companies needed real-world test data.
  • Defense agencies across the globe were preparing for bio-warfare scenarios.
  • Big Tech and biometric surveillance firms saw COVID-19 as the ultimate “lab-to-world” rollout to study population response, control, and adaptation.

Testing a virus in a large, densely populated country like India would provide valuable genetic, sociological, and resistance-related data. All under the cover of “tropical diseases” or “seasonal flu.”


🧬 What If We Were the Guinea Pigs?

It’s time we ask hard questions:

  • Why did several Indian virologists report seeing “COVID-like” virus structures in samples between 2018–2019 but were told to reclassify them?
  • Why did India react faster to the Wuhan outbreak than most countries — imposing lockdowns and travel bans before the first wave officially hit?
  • Why did seroprevalence studies in some Indian states in 2020 show 30-50% exposure when official COVID-19 cases were still in thousands?

Were we already immune? Or had we unknowingly been field-tested?


🔍 Final Thoughts: The Truth Demands Light

We may never get official confirmation. But signs, whispers, and patterns matter. COVID-19 wasn’t just a pandemic — it was a global experiment in virology, power, and obedience. And if India was a silent player — knowingly or unknowingly — it’s time the public knew.

We at Nishani.in aren’t afraid to question the unquestioned.

Let the truth breathe. Let history be rewritten by the people, not by the ones who profited from the panic.


📢 Sound Off: Have you or someone you know had unexplained flu-like illness in 2018 or 2019? Share your story. The silence ends here.

#NishaniIn #TruthComesFirst #BiowarfareOrBlunder #COVIDBeforeCOVID #AIIMS2018Flu #FieldTestedIndia

Comments

comments

 
Post Tags:

Hi, I’m Nishanth Muraleedharan (also known as Nishani)—an IT engineer turned internet entrepreneur with 25+ years in the textile industry. As the Founder & CEO of "DMZ International Imports & Exports" and President & Chairperson of the "Save Handloom Foundation", I’m committed to reviving India’s handloom heritage by empowering artisans through sustainable practices and advanced technologies like Blockchain, AI, AR & VR. I write what I love to read—thought-provoking, purposeful, and rooted in impact. nishani.in is not just a blog — it's a mark, a sign, a symbol, an impression of the naked truth. Like what you read? Buy me a chai and keep the ideas brewing. ☕💭   For advertising on any of our platforms, WhatsApp me on : +91-91-0950-0950 or email me @ support@dmzinternational.com